Search company, investor...

Founded Year

2005

Stage

Private Equity | Alive

Total Raised

$50M

Last Raised

$50M | 4 yrs ago

About THREAD

THREAD is a company that focuses on providing a decentralized clinical trial platform in the healthcare and life sciences industry. The company offers a platform and supporting services that enable biopharma, CROs, and life science organizations to remotely capture data from participants and sites during, in-between, and in lieu of in-clinic visits. The platform includes features such as electronic consent (eConsent), electronic clinical outcome assessment (eCOA), sensors, reminders, and telehealth virtual visits. It was founded in 2005 and is based in Tustin, California.

Headquarters Location

155 El Camino Real

Tustin, California, 92780,

United States

(833) 469-3376

Loading...

THREAD's Product Videos

ESPs containing THREAD

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTH ➡MARKET STRENGTH ➡LEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare & Life Sciences / Drug R&D Tech

The decentralized clinical trials market offers various solutions that allow for remote participation in clinical trials, including telemedicine, mobile health applications, and wearable devices. By removing the need for frequent visits to clinical trial sites, decentralized trials can improve patient enrollment, retention, and overall trial efficiency. Additionally, decentralized trials can enhan…

THREAD named as Outperformer among 15 other companies, including ObvioHealth, Curebase, and Huma.

THREAD's Products & Differentiators

    Platform

    THREAD's technology platform is a fully integrated suite of features that allow its customers to perform a decentralized clinical trial. Platform features include electronic Consent, Telehealth, electronic Source Data Capture, Analytics, Patient Mobile Application and others

Loading...

Research containing THREAD

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned THREAD in 1 CB Insights research brief, most recently on Jul 18, 2022.

Expert Collections containing THREAD

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

THREAD is included in 2 Expert Collections, including Digital Health.

D

Digital Health

10,804 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

T

Telehealth

2,856 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

THREAD Patents

THREAD has filed 13 patents.

The 3 most popular patent topics include:

  • fertility
  • genetics
  • germ cells
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/22/2022

8/22/2023

Embryologists, Germ cells, Fertility, Genetics, Reproduction

Grant

Application Date

7/22/2022

Grant Date

8/22/2023

Title

Related Topics

Embryologists, Germ cells, Fertility, Genetics, Reproduction

Status

Grant

Latest THREAD News

Thread Launches In AWS Marketplace To Expand Solutions And Simplify Customer Procurement Process

Jun 19, 2023

Expanded relationship offers life science organizations THREAD's suite of technology solutions in AWS Marketplace Cary, NC /PRNewswire/ - THREAD®, a leading decentralized research, electronic clinical outcome assessment (eCOA) and consulting services provider, announced today that it is expanding its relationship with Amazon Web Services (AWS) to simplify the procurement process for life sciences organizations by listing its services in AWS Marketplace . The new offering provides an easier and more cost-effective solution for biopharmaceutical companies and clinical research organizations (CROs) to access THREAD's patient-first research capabilities. Customers will now be able to enjoy the simplified procurement that AWS Marketplace offers through consolidated billing, predefined contractual agreements, and cost-effective pricing structure. In addition, AWS customers can maximize existing investments and enterprise discounts on AWS to support funding their research study budgets for decentralized research studies and eCOA technology solutions via THREAD. "AWS Marketplace makes it simpler for life science organizations to access high-quality SaaS offerings built on AWS," said Dan Sheeran, general manager, Healthcare and Life Sciences at AWS. "With THREAD now available in AWS Marketplace, THREAD is creating a better procurement pathway for their life science customers purchasing enterprise clinical technologies to accelerate and modernize research. We're proud to support THREAD as they work to make clinical research more patient centric through decentralized methods and eCOA." THREAD's next-generation technology offerings, built on AWS, serve as the backbone for many modern clinical studies. THREAD's omni-channel, no-code SaaS technology provides an opportunity to scale more efficient patient-first clinical research that improves access for eligible research participants and captures higher quality data. By bringing THREAD's technology solutions to AWS Marketplace, THREAD continues to demonstrate its commitment to scale patient-centered research via a leading technology and cloud solution. David Godwin, Chief Revenue Officer of Allucent, expressed his enthusiasm for the relationship between THREAD and AWS, stating, "As a long-standing customer of both THREAD and AWS, I am excited about this new development in the THREAD and AWS relationship and the availability of THREAD in AWS Marketplace. Allucent is eager to continue working with THREAD and AWS as we strive to scale patient-first research throughout our organization." "We are thrilled to expand our work with AWS and offer this simplified procurement model to our customers," said John Reites, co-founder and CEO, THREAD. "Our customers can now benefit from the scalability of THREAD's platform powered by AWS with less friction and greater cost efficiency." Learn more my visiting: https://www.threadresearch.com/aws About THREAD THREAD's® purpose is to leverage its decentralized research platform to enable studies for everyone, everywhere. The company's uniquely combined clinical research technology and consulting services help biopharma and CROs to design, operate, and scale next-generation research studies and electronic clinical outcome assessments (eCOA) programs for participants, sites, and study teams. Through its comprehensive platform and scientific expertise, THREAD empowers studies to be accessible, efficient, and centered on the patient. Backed by health care investors Water Street Healthcare Partners and JLL Partners, THREAD is recognized as a leader by Everest Group's Decentralized Clinical Trial Product PEAK Matrix® Assessment 2021/2022 and positioned in the Leader's Category of the 2022 IDC MarketScape for R&D Decentralized Clinical Trial Technology Solutions Vendor Assessment 2022. Visit  THREADresearch.com  to learn more. Source: THREAD Copyright 2023 PR Newswire. All Rights Reserved This website uses cookies to ensure you get the best experience on our website. Learn more Got it!

THREAD Frequently Asked Questions (FAQ)

  • When was THREAD founded?

    THREAD was founded in 2005.

  • Where is THREAD's headquarters?

    THREAD's headquarters is located at 155 El Camino Real, Tustin.

  • What is THREAD's latest funding round?

    THREAD's latest funding round is Private Equity.

  • How much did THREAD raise?

    THREAD raised a total of $50M.

  • Who are the investors of THREAD?

    Investors of THREAD include Water Street Healthcare Partners and JLL Partners.

  • Who are THREAD's competitors?

    Competitors of THREAD include Science 37, ObvioHealth, Medidata, ClinOne, Jeeva and 7 more.

  • What products does THREAD offer?

    THREAD's products include Platform and 4 more.

Loading...

Compare THREAD to Competitors

Medable Logo
Medable

Medable operates as a global platform for decentralized clinical trials. It solves the systemic challenges inherent in modern clinical trials including access, interoperability between systems, and inefficient technology experiences. Medable was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.

Curebase Logo
Curebase

Curebase provides decentralized clinical research software solutions. It reduces recruitment times, automates manual steps, and lets drug companies distribute their trials to clinics. It was founded in 2017 and is based in San Francisco, California.

Reify Health Logo
Reify Health

Reify Health is a company focused on improving the clinical trial process within the healthcare industry. The company offers cloud-based software that accelerates patient enrollment in clinical trials, thereby facilitating the development of new therapies. Reify Health primarily serves the healthcare and biopharma industries. The company was formerly known as ZeroSum Health. It was founded in 2012 and is based in Boston, Massachusetts.

Healint Logo
Healint

Healint is a behavior analytics platform that helps patients and families make healthcare decisions. Its platform provides a migraine tracking and reporting system that provides insights on medication satisfaction, dosing regimens, and new prescriptions. The company was founded in 2013 and is based in Singapore, Singapore.

B
BloqCube

Bloqcube develops cloud-based software enabling distributed and remote clinical trials with storage and real-time reporting of clinical data. It focuses on accelerating clinical trials using modern technology and built integrated clinical trials management and finance systems that enable life science companies to automate trials, monitor in real-time, and deliver immutable data, and more. The company was founded in 2017 and is based in Piscataway, New Jersey.

Medidata Logo
Medidata

Medidata provides web-based technology for streamlining the design, planning, and management of key aspects of the clinical development processes. It helps in protocol development, investigator benchmarking and budgeting, contract research organization benchmarking and budgeting, and the capture, management, analysis, and reporting of clinical trial data. It was founded in 1999 and is based in New York, New York. In October 2019, Medidata Solutions was acquired by Dassault Systemes.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.